Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
AJNR Am J Neuroradiol. 2010 Aug;31(7):1261-5. doi: 10.3174/ajnr.A2085. Epub 2010 Apr 1.
The larynx is a rare site for primary NHL. Fewer than 100 cases have been reported in the literature, with the largest imaging review involving only 4 patients. We describe the findings of laryngeal lymphoma on CT, PET, and MR imaging and identify features that may distinguish laryngeal lymphoma from the far more common laryngeal squamous cell carcinoma.
Multi-institutional retrospective chart review revealed 20 patients with histopathologically proved laryngeal lymphoma. Pretreatment CT, PET, and MR images were reviewed by a head and neck radiologist, focusing on extent of tumor, cervical lymph node involvement, and enhancement patterns.
Patients ranged from 30 to 90 years of age with a mean of 63 years at the time of initial diagnosis and a 2:1 female predominance. The average tumor size was 37 +/- 19 mm. In all patients, laryngeal lymphoma involved the supraglottis but also extended into the glottis (65%) and hypopharynx (60%). The subglottis was less frequently involved (35%). Laryngeal cartilage invasion and cervical lymphadenopathy were each seen in 20% of patients. Lymphoma was consistently FDG-avid (100%) and usually enhanced uniformly with iodinated contrast (73%). Necrosis and calcification were not seen in any cases.
Although laryngeal lymphoma is rare, particular imaging features suggest this diagnosis. A large uniformly enhancing supraglottic tumor without central necrosis and without cervical lymphadenopathy is a characteristic finding of lymphoma. Similar to squamous cell carcinoma, lymphoma may extend into the subglottis, pharynx, and laryngeal cartilages.
喉是原发性 NHL 的罕见部位。文献中报道的病例少于 100 例,最大的影像学综述仅涉及 4 例患者。我们描述了喉淋巴瘤在 CT、PET 和 MR 成像上的表现,并确定了可能将其与更为常见的喉鳞状细胞癌区分开来的特征。
多机构回顾性病历审查显示 20 例经组织病理学证实的喉淋巴瘤患者。由头颈部放射科医师对 CT、PET 和 MR 图像进行回顾性分析,重点关注肿瘤的范围、颈部淋巴结受累情况和增强模式。
患者年龄为 30 至 90 岁,平均初次诊断时为 63 岁,女性明显多于男性(2:1)。平均肿瘤大小为 37 +/- 19mm。在所有患者中,喉淋巴瘤均累及会厌,但也扩展至声门(65%)和下咽(60%)。声门下区较少受累(35%)。喉软骨侵犯和颈部淋巴结病各见于 20%的患者。淋巴瘤始终 FDG 摄取活跃(100%),并且通常用碘对比剂均匀增强(73%)。在任何病例中均未见坏死和钙化。
尽管喉淋巴瘤罕见,但特定的影像学特征提示该诊断。大的、均匀增强的会厌肿瘤无中心坏死且无颈部淋巴结病是淋巴瘤的特征性表现。与鳞状细胞癌类似,淋巴瘤可能延伸至声门下区、咽部和喉软骨。